Bill Ackman

Page 16 of 18

Berkshire Hathaway Inc. Annual Shareholders Meeting
Finance

Ackman’s Mondelez buyout plan pricey, even for Buffett

By
August 6, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
Finance

The real reasons for the pharma merger boom

By
July 28, 2015
157934085
Finance

Teva in talks to buy Allergan’s generic drug business

By
July 26, 2015
An Herbalife logo is shown on a poster at a clinic in the Mission District in San Francisco
Leadership

Herbalife wants Twitter to unmask troll

By
July 22, 2015
Janet Yellen testifies on Capitol Hill in Washington
Features

China’s GDP and Yellen talks to Congress– 5 things to know today

By Laura Lorenzetti and Geoffrey Smith
July 15, 2015
CNBC Events - Season 2014
Leadership

The highest paid hedge fund manager only made $1.3 billion last year

By
May 5, 2015
Shareholder activist conference disrupted by actual activists
Finance

Shareholder activist conference disrupted by actual activists

By
April 13, 2015
SEC Chair Mary Jo White
Finance

SEC’s Mary Jo White criticizes shareholder activism and Bill Ackman deal

By
March 19, 2015
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

The FBI is looking into possible Herbalife stock manipulation

By
March 13, 2015
Inside The South By Southwest (SXSW) Interactive Festival
Features

FBI probes Ackman and SXSW kicks off — 5 things to know today

By
March 13, 2015
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO: How to survive an activist attack

By
February 12, 2015
Passive investors crushed the activists in 2014
Finance

Passive investors crushed the activists in 2014

By
January 9, 2015
Icahn Enterprises L.P. To Ring The NASDAQ Stock Market Closing Bell
Leadership

Why activist investors are getting even more…active

By
December 3, 2014
Activist investors: The best (and worst) performers of 2014
Finance

Activist investors: The best (and worst) performers of 2014

By
December 3, 2014
Actavis CEO Brenton Saunders and Allergan CEO David Pyotton pose together on the floor of the New York Stock Exchange
Finance

Allergan CEO hands Botox maker to lawyer instead of consultant

By
November 17, 2014

Most Popular